Jennifer Erwin

Dr Jennifer A. Erwin is Chief Scientific Officer of Aluco Biosciences, developing small molecule epigenetic inhibitors for psychiatric and metabolic indications. She is internationally recognized leader in neurogenetics and epigenetics, with a research program that spans molecular mechanisms of brain development to the creation of novel therapeutics. She served as an Assistant Professor at Johns Hopkins University and the Lieber Institute for Brain Development. She earned her PhD as a National Science Foundation Predoctoral Fellow in Genetics from Harvard University, her Bachelors of Science from the Massachusetts Institute of Technology (Phi Beta Kappa), and completed postdoctoral training as a Hewitt Foundation Fellow at the Salk Institute in San Diego. 

Publications: https://scholar.google.com/citations?user=r1wp8XIAAAAJ&hl=en